ARSENICUM IODATUN

Manufacturer
Rxhomeo Private Limited d.b.a. Rxhomeo, Inc | Rxhomeo, Inc
Effective date
2016-01-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:07:28

Label at a glance#

ProductARSENICUM IODATUN
Active ingredientARSENIC TRIIODIDE
Label structure9 sections

Indications and uses

Hay Fever, Coryza

Storage and handling

Store in a cool dark place

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

ARSENICUM IODATUN HPUS 6X and Higher

USES

OTC - PURPOSE SECTION

Hay Fever, Coryza

INDICATIONS

INDICATIONS & USAGE SECTION

Condition listed above or as directed by the physician

DOSAGE

DOSAGE & ADMINISTRATION SECTION

Adults- Take 4 or 6 Tablets by mouth, three times daily or as suggested by physician. Children 2 years and older- take 1/2 the adult dose.

WARNINGS

WARNINGS SECTION

This product is to be used for self-limiting conditions

OTC - STOP USE SECTION

If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional

OTC - PREGNANCY OR BREAST FEEDING SECTION

As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medication out of reach of children

OTC - DO NOT USE SECTION

Do not use if capseal is broken or missing.

Close the cap tightly after use.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Lactose

STORAGE

STORAGE AND HANDLING SECTION

Store in a cool dark place

QUESTIONS OR COMMENTS

OTC - QUESTIONS SECTION

www.Rxhomeo.com | 1.888.2796642 | info@rxhomeo.com

Rxhomeo, Inc 9415 Burnet Road, Suite 312, Austin, TX 78758

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
63f39a63-5cd1-4016-bd86-2bbb0f6c3139Product name320240506
e5a77e9c-c528-733a-173d-914a234c024bProduct name520240506

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
15631-0524-0ARSENICUM IODATUN1 in 1 BLISTER PACKTABLET11
15631-0524-1ARSENICUM IODATUN4 in 1 BLISTER PACKTABLET41
15631-0524-2ARSENICUM IODATUN50 in 1 CONTAINERTABLET501
15631-0524-3ARSENICUM IODATUN100 in 1 CONTAINERTABLET1001
15631-0524-4ARSENICUM IODATUN250 in 1 CONTAINERTABLET2501
15631-0524-5ARSENICUM IODATUN500 in 1 CONTAINERTABLET5001
15631-0524-6ARSENICUM IODATUN1000 in 1 CONTAINERTABLET10001
15631-0524-7ARSENICUM IODATUN10000 in 1 CONTAINERTABLET100001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
15631-0524ARSENICUM IODATUN TABLET [RXHOMEO PRIVATE LIMITED D.B.A. RXHOMEO, INC]1Legacy NDC, 8 package rows20160116_481ca869-e695-4392-936c-9a84cb369bde.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

NDC Codes#

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
ARSENIC TRIIODIDE3029988O2TACTIB
LACTOSEJ2B2A4N98GIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a817bb4b-b3f3-4205-aeea-3e880504586e481ca869-e695-4392-936c-9a84cb369bde2016-01-12WarningsExact identifier
spl id: a817bb4b-b3f3-4205-aeea-3e880504586e
spl set id: 481ca869-e695-4392-936c-9a84cb369bde

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.